0000950170-24-094127.txt : 20240808
0000950170-24-094127.hdr.sgml : 20240808
20240808164504
ACCESSION NUMBER: 0000950170-24-094127
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240807
FILED AS OF DATE: 20240808
DATE AS OF CHANGE: 20240808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HARRISON THOMAS L
CENTRAL INDEX KEY: 0001247340
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 241189207
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
3
1
ownership.xml
3
X0206
3
2024-08-07
0
0001098972
AGENUS INC
AGEN
0001247340
HARRISON THOMAS L
3 FORBES ROAD
LEXINGTON
MA
02421
true
false
false
false
Stock Option
21.00
2023-10-02
2033-10-02
Common Stock
1250
D
1. Stock Options awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan (as amended). The Stock Options were granted prior to the 1 for 20 reverse stock split of the Issuer's common stock in April 2024 and initially represented Stock Options to purchase 25,000 shares of the issuer's common stock with an exercise price of $1.05.
Christine M. Klaskin, by Power of Attorney
2024-08-08